'Groundbreaking' studies on cannabis, back pain will need to be repeated in U.S.
October 22, 2025
6,719
510
47
8.29%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Npr Episodes Around October 22, 2025
See what was published immediately before and after this episode.
1:00Now Playing'Groundbreaking' studies on cannabis, back pain will need to be repeated in U.S.
YouTube Description
as posted by the channelNew research findings from Europe show that marijuana can help with chronic back pain.
The German company that ran the study says it expects to get approval to market the drug over there in a few months. That won’t be true in the U.S. — the company tells NPR it is being required to repeat the studies in the U.S. before seeking approval from regulators here. Because cannabis is a Schedule 1 drug, running large research trials comes with many obstacles, meaning it will likely be years before that additional research gets completed.
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.